This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07343/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07343/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07343/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07343/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07343/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07343
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n4:DB07343 n12:DB07343
dcterms:title
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE
adms:identifier
n6:99443814 n9:ADB n10:448532 n11:395301 n13:DB07343
n7:IUPAC-Name
n8:271B622B-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B6231-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B6230-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B622D-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B622E-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B622F-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B6229-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B6227-363D-11E5-9242-09173F13E4C5 n8:271B622A-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B6228-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B6237-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B6238-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B6232-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B6233-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B6235-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B6234-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B6236-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B623D-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B623F-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B6240-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B623C-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B623B-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B623E-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B622C-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B6239-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B623A-363D-11E5-9242-09173F13E4C5